Risk-averse Control and Dynamic Optimization Bridging the Gap Between Robust and Stochastic Control
From 01-01-2018 to 31-12-2021
Description
Ubiquitous and inevitable as it is, uncertainty needs to be taken into account when we make decisions. In engineering, automated decision making is referred to as control. There exist two tools in an engineer's toolbox when it comes to designing a control system which is resilient to uncertainty. The first is the so-called robust approach where we try to protect the system against worst-case events which, nevertheless, are unlikely to happen in practice. The adoption of such a pessimistic strategy leads to poor performance. The second approach is known as stochastic, where we opt for policies which lead to optimal average performance. However, the impossibility of fully capturing the underlying distribution creates a yawning chasm between theory - with all its convenient assumptions - and practice. These two decision making practices have been being studied separately with no obvious connection to another and, most importantly, without any halfway choices. In this project we will propose a new decision making paradigm which bridges the gap between the robust and stochastic approaches using the concept of risk. This will furnish the designer with a new powerful tool and will enable the operation of systems in highly uncertain contexts. The key contributions of this project will be (i) an arsenal of theoretical analysis and design tools, (ii) computational methods and software to facilitate the technological uptake of our developments (iii) demonstration on a bioreactor.
Team
- Jan Van Impe, Promoter (External)
- Panagiotis Patrinos, Promoter
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Project - FWO Research Project
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.